Joel Isaacson & Co’s Avanos Medical AVNS Stock Holding History

Joel Isaacson & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-287	Closed	-$11K	–	204
2016 Q4	$11K	Hold	287	–	–	﹤0.01%	486
2016 Q3	$10K	Hold	287	–	–	﹤0.01%	535
2016 Q2	$9K	Sell	287 -87	-23%	-$2.67K	﹤0.01%	546
2016 Q1	$11K	Buy	374 +87	+30%	+$2.32K	﹤0.01%	559
2015 Q4	$10K	Sell	287 -50	-15%	-$1.55K	﹤0.01%	549
2015 Q3	$10K	Hold	337	–	–	﹤0.01%	571
2015 Q2	$14K	Sell	337 -12	-3%	-$539	﹤0.01%	548
2015 Q1	$17K	Sell	349 -10	-3%	-$463	﹤0.01%	512
2014 Q4	$16K	Buy	+359	New	+$14.1K	﹤0.01%	456

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Joel Isaacson & Co's AVNS Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 287 shares — an estimated $11K sold.

Joel Isaacson & Co first reported a position in AVNS in Q4 2014 and held it in 9 quarters. The position peaked at $17K in Q1 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

Joel Isaacson & Co reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
Joel Isaacson & Co sold 287 Avanos Medical shares in Q1 2017, an estimated $11K.
Joel Isaacson & Co first reported a position in Avanos Medical in Q4 2014 and held it in 9 quarters.
Joel Isaacson & Co's Avanos Medical position peaked at $17K in Q1 2015.
335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.